FDA official logo
GSRS logoPFDA official logo

OPORTUZUMAB MONATOX

UNII:945CY7ZMI2
Formula:
Preferred Substance Name:OPORTUZUMAB MONATOX

  • 945228-48-8
  • 4D5MOCB-ETA
  • ANTI-EPCAM ANTIBODY FRAGMENT-PSEUDOMONAS-EXOTOXIN FUSION PROTEIN
  • IMMUNOGLOBULIN G, ANTI-(TUMOR ANTIGEN 17-1A) (HUMAN-MOUSE SINGLE CHAIN FRAGMENT) FUSION PROTEIN WITH 252-608-EXOTOXIN A (SYNTHETIC PSEUDOMONAS)
  • IMMUNOGLOBULIN SCFV FUSION PROTEIN, ANTI-(HOMO SAPIENS TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 1 (TACSTD1, GASTROINTESTINAL TUMOR-ASSOCIATED PROTEIN 2, GA733-2, EPITHELIAL GLYCOPROTEIN 2, EGP-2, EPITHELIAL CELL ADHESION MOLECULE EP-CAM, KSA, KS1/4 ANTIGEN, M4S1, TUMOR ANTIGEN 17-1A, CD326)) HUMANIZED MONOCLONAL ANTIBODY SCFV FUSED WITH PSEUDOMONAS AERUGINOSA EXOTOXIN A
  • IMMUNOGLOBULIN SCFV FUSION PROTEIN, ANTI-(HOMO SAPIENS TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 1 (TACSTD1, GASTROINTESTINAL TUMOR-ASSOCIATED PROTEIN 2, GA733-2, EPITHELIAL GLYCOPROTEIN 2, EGP2, EPITHELIAL CELL ADHESION MOLECULE EP-CAM, KSA, KS1/4 ANTIGEN, M4S1, TUMOR ANTIGEN 17-1A, CD326)) HUMANIZED MONOCLONAL ANTIBODY SCFV FUSED WITH PSEUDOMONAS AERUGINOSA EXOTOXIN A; HEXAHISTIDYL-HUMANIZED SCFV (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (78%)-IGKJ1*01, I126>L) (11.3.9) (7-118)-26-MER LINKER-VH (HOMO SAPIENS IGHV7-4-1*02-(IGHD)-IGHJ4*01, V124>L) (8.8.9) (145-260))-20-MER LINKER-PSEUDOMONAS AERUGINOSA EXOTOXIN A (ETA) (277-633 PRECURSOR FRAGMENT, CONTAINING DOMAIN II (281-393) WITH FURIN PROTEOLYTIC CLEAVAGE SITE (302-313), DOMAIN IB (394-433), DOMAIN III (434-637)) (281-637)-HEXAHISTIDYL-LYSYL-ASPARTYL-GLUTAMYL-LEUCYL
  • MOAB, HUMANIZED, SINGLE CHAIN:PSEUDOMONAS EXOTOXIN A IMMUNOTOXIN FUSION PROTEIN, VB4-845 TO EPCAM
  • OPORTUZUMAB MONATOX [INN]
  • OPORTUZUMAB MONATOX [USAN]
  • OPORTUZUMAB MONATOX [WHO-DD]
  • PROXINIUM
  • VB4845
  • VB4-845
  • VB-4845
  • VICINIUM
  • XD60E5X7FI




UNII - 945CY7ZMI2 | UNII Search Service